In addition, INC patients develop an insensitivity to the actions of growth hormone (GH) and insulin-like growth factor 1 (IGF1), as noted in other patients suffering from advanced CKD, which further hinders growth and can be overcome by treatment with recombinant human GH [22,32,33]. The gene discussed is IGF1; the disease is chronic kidney disease.